Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
PhytoHealth Corporation
Age
20–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women who are able to provide informed consent
Age 20 years and older
Diagnosis of stage II to III breast cancer
Patients who had undergone surgery for breast cancer treatment.
Planning to receive anthracycline -based adjuvant chemotherapy
Have adequate bone marrow, liver, and renal function
ECOG ≦1
Willing and able to complete quality of life questionnaires.
You may not be if
Pregnancy or lactating women.
Baseline BFI score \>3.
History of chronic fatigue syndrome, uncontrolled active infection, active cardiac disease, poor controlled hypertension or diabetes mellitus, any serious medical condition, psychiatric illness, and regular steroid therapy as determined by investigators.
History of previous breast cancer or other malignancy within the past 3 years with the exception of adequately treated basal cell carcinoma, squamous cell skin cancer, or thyroid cancer.
Known severe allergy to Astragalus membranaceus or its mayor extracts (polysaccharides).
Clareo Health | PG2 Breast Cancer Evaluation in Adjuvant Medicine Study
